MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, vol.26, no.2, pp.62-68, 2017 (ESCI)
Objective: The aim of the study was to estimate the radiation-absorbed doses and to study the in vivo and in vitro stability as well as pharmacokinetic characteristics of lutetium-177 (Lu-177) prostate-specific membrane antigen (PSMA)-617.